VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 1 filers reported holding VIRACTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,261 | -26.0% | 5,059 | +0.3% | 0.00% | – |
| Q2 2023 | $7,109 | +28336.0% | 5,042 | -67.7% | 0.00% | -100.0% |
| Q1 2023 | $25 | +13.6% | 15,599 | +2.4% | 0.00% | 0.0% |
| Q4 2022 | $22 | -99.8% | 15,238 | +610.4% | 0.00% | – |
| Q3 2022 | $9,000 | +125.0% | 2,145 | +136.2% | 0.00% | – |
| Q2 2022 | $4,000 | -55.6% | 908 | -51.5% | 0.00% | – |
| Q1 2022 | $9,000 | -60.9% | 1,873 | -70.7% | 0.00% | – |
| Q4 2021 | $23,000 | +228.6% | 6,391 | +589.4% | 0.00% | – |
| Q3 2021 | $7,000 | 0.0% | 927 | +44.6% | 0.00% | – |
| Q2 2021 | $7,000 | -88.1% | 641 | -90.0% | 0.00% | -100.0% |
| Q1 2021 | $59,000 | – | 6,386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 288,571 | $421,314 | 0.28% |
| BVF INC/IL | 3,614,662 | $5,277,407 | 0.22% |
| Samsara BioCapital, LLC | 689,709 | $1,006,975 | 0.22% |
| Rubric Capital Management LP | 1,330,983 | $1,943,235 | 0.08% |
| HAMILTON LANE ADVISORS LLC | 35,791 | $52 | 0.02% |
| MAI Capital Management | 426,916 | $623,297 | 0.01% |
| Jasper Ridge Partners, L.P. | 92,939 | $135,691 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 17,500 | $25,550 | 0.01% |
| RP Management, LLC | 3,700 | $5,402 | 0.01% |
| Laurion Capital Management LP | 698,000 | $1,019,080 | 0.01% |